C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2006
11/09/2006	US20060252037 Expression vector comprising antisense nuclelotide sequence which decrease exxpression from kinase suppressor of RAS (KRAS) for use in the treatment and prevention of cell proliferative disorders
11/09/2006	US20060252036 Alteration of rab38 function to modulate mammalian pigmentation
11/09/2006	US20060252035 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
11/09/2006	US20060252034 Novel protein containing ring finger domaine r1p4
11/09/2006	US20060252028 Method of assaying interaction between proteins
11/09/2006	US20060251763 Phospholipase variants
11/09/2006	US20060251682 soluble and stable in physiological media; have an additional Cys residue compared with the wild type; utilised for the therapy of grass pollen-induced allergies
11/09/2006	US20060251681 Culturing a eukaryotic host cell transformed with a recombinant DNA construct including a Venezuelan equine encephalitis replicon vector, and at least one DNA fragment encoding any one of the Marburg virus proteins
11/09/2006	US20060251679 Protein or peptide capable of being fused to ferritin without interfering with the polymeric self-assembly of the resulting fusion protein; metal scavenging
11/09/2006	US20060251677 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
11/09/2006	US20060251671 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/09/2006	US20060251667 Recombinant nucleic acid useful for inducing protective immune response against allergens
11/09/2006	US20060251665 Vaccines
11/09/2006	US20060251660 Antibodies to human IL-1beta
11/09/2006	US20060251655 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same
11/09/2006	US20060251648 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement
11/09/2006	US20060251646 Anti-tirc7 antibodies in therapy of inflammatiory diseases
11/09/2006	US20060251643 Regulatory zinc finger proteins
11/09/2006	US20060251635 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
11/09/2006	US20060251632 Modulation of myostatin and use thereof in cell transplantation-based treatment of muscle disease
11/09/2006	US20060251627 Targeted vectors for cancer immunotherapy
11/09/2006	US20060251626 Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors
11/09/2006	US20060251625 MCV MC160 compositions and methods
11/09/2006	US20060251623 Packaged virus-like particles
11/09/2006	US20060251621 Ocular gene therapy
11/09/2006	US20060251620 Inducible alphaviral/orip based gene expression system
11/09/2006	US20060251616 Migration of hematopoietic stem cells and progenitor cells to the liver
11/09/2006	US20060251604 Method for diagnosing alopecia
11/09/2006	US20060251314 Method and device for selectively targeting cells within a three-dimensional specimen
11/09/2006	DE19952969B4 Aus Pflanzen stammende, Asparagin-spezifische Endoprotease-cDNA und -Gen Plant-derived, asparagine-specific endoprotease cDNA and gene
11/09/2006	DE102005021365A1 Transgene Expressionskassetten zur Expression von Nukleinsäuren in Blütengeweben von Pflanzen The transgenic expression cassettes for expression of nucleic acids in floral tissues of plants
11/09/2006	DE102005015832A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications
11/09/2006	CA2821389A1 Novel method for preventing or treating m tuberculosis infection
11/09/2006	CA2614478A1 Pericarp-preferred regulatory element
11/09/2006	CA2609561A1 Polypeptide, vaccine and use thereof
11/09/2006	CA2607772A1 Promoter for introducing extracellular substance into mammalian ovum and introduction method
11/09/2006	CA2607757A1 Abfb-1 gene of penicillium funiculosum
11/09/2006	CA2607532A1 Amplification and cloning of single dna molecules using rolling circle amplification
11/09/2006	CA2607344A1 Wheat having new starch and method for producing it
11/09/2006	CA2607341A1 Diagnosis and treatment of endometriosis
11/09/2006	CA2607256A1 Composition and methods for cancer diagnosis utilizing the mir 17-92 cluster
11/09/2006	CA2607185A1 Intracellular active agents
11/09/2006	CA2607173A1 Gene therapy for neurometabolic disorders
11/09/2006	CA2607160A1 Transgenic expression cartridges for expressing nucleic acids in the flower tissue of plants
11/09/2006	CA2607150A1 Glucagon-like-peptide-2 (glp-2) analogues
11/09/2006	CA2607133A1 Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer
11/09/2006	CA2607095A1 Compositions and methods for modulating dopamine neurotransmission
11/09/2006	CA2606876A1 Fluorescent proteins and uses thereof
11/09/2006	CA2606766A1 Abfb-2 gene of penicillium funiculosum
11/09/2006	CA2606668A1 Antiviral peptide against hepatitis c virus
11/09/2006	CA2606490A1 Gene therapy for spinal cord disorders
11/09/2006	CA2606489A1 Method for identification of compound having antidepressant effect
11/09/2006	CA2606450A1 Anti-platelet membrane glycoprotein vi monoclonal antibody
11/09/2006	CA2606341A1 Genemap of the human genes associated with crohn's disease
11/09/2006	CA2606177A1 Novel polypeptide and use thereof
11/09/2006	CA2606162A1 Peptide having antianxiety activity and screening method therefor
11/09/2006	CA2606105A1 Preparation of soluble n-protein/truncated p-protein complexes or n-proteins soluble in a virus of the paramyxoviridae family and use thereof in vaccines
11/09/2006	CA2604608A1 Antibody directed against gastrin-releasing peptide precursor and use thereof
11/09/2006	CA2600084A1 Transgenic plant for producing polyglutamic acid
11/09/2006	CA2591586A1 Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors
11/08/2006	EP1720015A1 Process for producing biochip, probe solution, and biochip
11/08/2006	EP1720014A1 Method of judging the extent of vasculopathy
11/08/2006	EP1719819A1 Method for screening h-type rnase inhibitor of reverse transcriptase
11/08/2006	EP1719818A1 Method for the preparation of L-amino acids using strains of the enterobacteriaceae family with increased expression of ytfQ-ORF
11/08/2006	EP1719817A1 Carcinostatic method using brca1-bard1 pathway
11/08/2006	EP1719816A1 Mechanism of separating and purifying dna and so on
11/08/2006	EP1719815A1 Method of detecting bifidobacterium infantis
11/08/2006	EP1719814A1 Process for the preparation of L-amino acids using strains of the family Enterobacteriaceae
11/08/2006	EP1719780A2 Mammalian cytokine-like polypeptide-10
11/08/2006	EP1719779A2 Antibodies against Matin
11/08/2006	EP1719778A1 3'-terminal nucleoside unit containing phosphoramidite
11/08/2006	EP1719777A1 Electrochemically active ligand for sequence-specific detection of double-stranded nucleic acid molecule
11/08/2006	EP1719512A2 Sarsasapogenin and smilagenin for treating cognitive dysfunctions
11/08/2006	EP1719511A2 N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide, a pharmaceutical composition comprising the same and use thereof
11/08/2006	EP1718965A2 Ccn1 transgenic animals
11/08/2006	EP1718769A2 Polony fluorescent in situ sequencing beads
11/08/2006	EP1718762A1 Antisense oligonucleotide modulation of stat3 expression
11/08/2006	EP1718758A1 Reduction of spontaneous mutation rates in cells
11/08/2006	EP1718754A1 Plants modified with mini-chromosomes
11/08/2006	EP1718753A2 Methods for making and using molecular switches involving circular permutation
11/08/2006	EP1718752A1 A novel hansenula polymorpha gene coding for alpha 1,6-mannosyltransferase and process for the production of recombinant glycoproteins with hansenula polymorpha mutant strain deficient in the same
11/08/2006	EP1718751A2 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
11/08/2006	EP1718750A1 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof
11/08/2006	EP1718749A1 Humanized antibody
11/08/2006	EP1718748A1 Therapeutic molecules and methods for generating and/or selecting same
11/08/2006	EP1718747A2 Stabilized rnas as transfection controls and silencing reagents
11/08/2006	EP1718746A1 Induction of apoptosis by inhibition of sirtuin sirt1 expression
11/08/2006	EP1718745A1 Generation of recombinant genes in prokaryotic cells by using two extrachromosomal elements
11/08/2006	EP1718744A1 Plasmid purification
11/08/2006	EP1718742A1 Fungall cell wall degrading enzyme
11/08/2006	EP1718741A2 Treatment of neurodegenerative diseases by the use of atp7a
11/08/2006	EP1718739A2 Methods of refolding mammalian glycosyltransferases
11/08/2006	EP1718737A1 Cancerous disease modifying antibodies
11/08/2006	EP1718734A1 Methods for genetic diversification in gene conversion active cells
11/08/2006	EP1718677A2 Monovalent antibody fragments useful as therapeutics
11/08/2006	EP1718676A1 Anti-clusterin oligoclonal antibodies for diagnosis and prediction of the aggressiveness of tumours, diagnostic method and related kits
11/08/2006	EP1718663A2 Chimeric promoters for use in plants
11/08/2006	EP1718662A2 Multiplex detection probes
11/08/2006	EP1718659A1 Vectors having both isoforms of beta-hexosaminidase and uses of the same
11/08/2006	EP1718367A1 Muc1 antagonist enhancement of death receptor ligand-induced apoptosis

1 ... 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 ... 4023